F-18 FDG PET Scan and Gallium Scan in Adult-Onset Still's Disease suspected first. After discussing with the patient, thoracoscopic mediastinal lymph node biopsy was performed. Fifteen lymph nodes were taken and the results showed histiocytic infiltration in sinusoid area and anthracotic pigment deposition. Reactive lymphoid follicle hyperplasia and focal fibrocalcified nodule formation were also noted. No tumor cell was seen. Gallium-67 (Ga-67) scan was conducted and no gallium-avid tumor was seen throughout the whole body ( Figure 2 ). The laboratory data were negative for antinuclear antibodies, rheumatoid factor-immunoglobulin M, and extractable nuclear antibody, while alanine aminotransferase was high. The final diagnosis was AOSD. In our case, there were no symptoms or signs of either high fever or debilitating joint although the FDG PET showed multiple FDG-avid lesions in the whole body scan. According to the experience of our rheumatologists, methylprednisolone (Metisone) 4 mg/day and non-steroidal anti-inflammatory drugs were prescribed initially and the response to treatment was good. Six months later, the followup PET/CT showed complete remission of the FDG-avid lesions seen in the previous PET/CT ( Figure 1 ) and the patient's symptoms relieved. A written informed consent was obtained from the patient.
DISCUSSION
Adult-onset Still's disease is a chronic systemic inflammatory disorder. Other malignancies and rheumatic diseases should be ruled out first before a diagnosis of AOSD is established. The etiology of AOSD remains unknown. Both infectious etiology and genetic factors have been suggested, although not confirmed. AOSD is characterized by spiking fever, leukocytosis, rash, and arthralgia. Some patients may also develop sore throat, lymphadenopathies, and hepatosplenomegaly. [5] [6] [7] [8] The therapeutic decision depends on the severity of disease and subsequent treatment decisions should be made in accordance with the clinical response. If the symptoms are mild, patients may respond to non-steroidal anti-inflammatory drugs. However, some still need low-dose glucocorticoid therapy to control the inflammatory response. If the symptoms are moderate such as high fever or debilitating joint, patients should receive glucocorticoid treatment initially. If the symptoms are more severe such as organ involvement which may be life-threatening, high dose glucocorticoids or even pulse therapy should be considered. [9] [10] [11] [12] In this study, we present the FDG PET/CT and Ga-67 scan findings of a patient who met the Yamaguchi classification criteria for AOSD. The FDG PET/CT scan was not helpful in diagnosing AOSD in this case since lymphoma could not be ruled out. However, the FDG PET/CT scan results were useful for evaluating the distribution Figure 1 . F18-fluorine-18-deoxyglucose positron emission tomography/computed tomography scan performed before treatment showed (upper row) increased fluorine-18-deoxyglucose uptake at bilateral neck, axillae, mediastinum, bilateral pulmonary hili, abdominal para-aortic, iliac regions, and inguinal regions, and also in spleen (arrow). Lymphoma involving aforementioned areas was considered first. However, a biopsy was performed and no evidence of malignancy was found. Adult-onset Still's disease was diagnosed and patient received medical treatment. Six months later, follow-up F18-fluorine-18-deoxyglucose positron emission tomography/computed tomography scan (lower row) showed complete remission of the fluorine-18-deoxyglucose-avid lesions. and severity of the disease. A negative Ga-67 scan could be beneficial as it would exclude lymphoma. After the diagnosis of AOSD was established, the patient received nonsteroidal anti-inflammatory drugs and glucocorticoids with a good response. Disease activity and therapeutic response were monitored by FDG PET/CT and the findings of a scan performed six months after treatment were negative. 13 In this case, we were unable to diagnose bone marrow involvement since no bone marrow biopsy was performed. There was mild and diffuse increase of FDG uptake in the bone marrow with a maximum standard uptake value of 2.5 in the spines, which was similar to the FDG uptake in the liver. According to a study by Inoue et al., 14 a bone marrow F-18 FDG uptake greater than or equal to that of the liver may indicate bone marrow hyperactivity. Therefore, bone marrow involvement could not be ruled out in this case. The PET/CT six months later revealed that the maximum standard uptake value decreased to 2.0 in the spines and was less than that in the liver (Figure 3 ).
The treatment of AOSD remains largely empirical, relying so far on a few prospective or retrospective studies and not on doubleblinded randomized trials with suitable sample sizes. 12 In our case, there were no symptoms or signs of high fever, debilitating joint or lifethreatening complications although the FDG PET showed multiple FDG-avid lesions in the whole body scan. According to the experience of our rheumatologists, low dose of corticosteroids was prescribed first and the response to treatment was good. The patient's symptoms and signs relieved and the follow-up PET/CT showed complete remission of these FDG-avid lesions six months later.
In conclusion, there is no definitive diagnostic imaging study for patients with AOSD. Our study suggests that FDG PET/CT combined with Ga-67 scan may be helpful in diagnosing patients with AOSD. In addition, the use of FDG PET/CT Figure 2 . A gallium-67 scan performed before treatment showed no gallium-avid tumor in whole body scan. Figure 3 . F18-fluorine-18-deoxyglucose positron emission tomography/computed tomography scan performed before treatment (left) showed mildly and diffusely increased fluorine-18-deoxyglucose uptake in spines (maximum standard uptake value= 2.5). Six months later, follow-up F18-fluorine-18-deoxyglucose positron emission tomography/computed tomography scan (right) showed lower fluorine-18-deoxyglucose uptake in spines (maximum standard uptake value= 2.0).
